Videos / Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice
In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Importance of early & effective treatment of mild to moderate acne

CV medications – Practical strategies to improve adherence

Cardiovascular risk and fatty liver disease

SGLT2s and renal protection

expert
Consultant Paediatric Immunologist & Paediatrician, Perth Children’s Hospital. Head, Department of Immunology, Child & Adolescent Health Service WA. Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines & Infectious Diseases, The Kids Research Institute Australia.